Q3 2025 Earnings Call November 14, 2025 10:00 AM ESTCompany ParticipantsDan Cuthbertson - General Manager of Investor RelationsC.

Many fintech startups chase donor funding over real markets, which experts say is detrimental to the companies ...

Operator: Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents Corp. Third Quarter 2025 Earnings Conference ...

Q3 2025 update. The fund trailed the Russell 2000 Growth Index due to stock selection. Learn more about our outlook.

"What they found was that of all new drugs approved in the last 20 years, 12% came from the SBIR/STTR program," said Jere Glover.

KORE (NYSE:KORE) suspended financial guidance for the remainder of fiscal year 2025 due to uncertainty from the announced ...

Heidi Crane noted a $0.3 million increase in net interest expense, which slightly offset operational gains. Net Revenue -- ...

Once a buzzword, the "digital middle platform" is now mired in what Gartner calls the "trough of disillusionment" —data keeps ...

In this episode of DEMO, host Keith Shaw sits down with Josh Goldlust, Vice President of Product Management at Genesys, to ...

In today's hypercompetitive business landscape, gut feelings and intuition alone no longer cut it. The modern business era ...

SAP's Jan Gilg shares insights on innovating your way to an adaptability that goes beyond mere resilience.